2015
- HDSA Releases 2015 Research Investor’s Report
- Looking Past the Spin: Results from a Clinical Trial of Cysteamine
- An existing drug could give a boost to HD brain cells – but it may need more testing before it’s back in the clinic
- Raptor Plans to Advance RP103 in a Registration Study
- New HD Career Development Fellowship Announced by Huntington’s Disease Society of America
- Through the eyes of a friend: changes in mood and behavior in early HD
- Huntington’s Disease Society of America Adds Call Center Component to HD TrialFinder
- Huntington’s Disease Society of America Receives 4-Star Rating From Charity Navigator
- A multiple sclerosis drug that works for Huntington’s disease: the real deal or too good to be true?
- Huntington’s Disease Society of America Now Accepting Applications for the 2016 Donald A. King Summer Research Fellowship
- Huntington’s Disease Society of America’s New York City Marathon Team Raises More Than $125,000
- Fourth Annual Strike Out HD Bowling Event Hosted by New York Giant Geoff Schwartz Raises Nearly $50,000
- HDBuzz- Liftoff: First humans treated with gene silencing drugs for HD!
- HDBuzz primer: Clinical trial designs and phases
- Huntington’s Disease Society of America Announces 2015 HD Human Biology Project Grant Recipients
- FDA Opens 60 Day Open Comment Period
- Hundreds of HD Families Join FDA Hearing to Shape Drug Development for Huntington’s Disease
- HDBUZZ- A Few Bad Seeds: Using Brain Fluid to Grow Clumps in Brain Cells
- CNN “NEW DAY” Hosts Alisyn Camerota & Chris Cuomo raise $10,000 for the Huntington’s Disease Society of America
- Deadline To Tell Us Your Thoughts Has Been Extended!
- HDSA Announces 2016 Call for Letters of Interest for Center of Excellence Program
- Patient-Focused Drug Discovery Meeting at the FDA on Huntington’s Disease
- Scientists identify genetic factors that alter the clinical onset of HD in landmark study
- Would ewe believe it? GM1, sheep and Huntington’s disease
- ISIS Pharmaceuticals Initiates Clinical Study of Huntingtin Lowering Drug in HD Patients
- 30th Annual Convention is a Huge Success for the Huntington’s Disease Society of America
- Calling all HD families: Our time to be heard is now!
- Huntington’s Disease Society Of America Receives CHARITYWATCH Top-Rated Status
- HDSA Supports 21st Century Cures Act
- NIH Names Walter J. Koroshetz, M.D. Director of the National Institute of Neurological Disorders and Stroke
- Life in HD Earns Rave Reviews for the Huntington’s Disease Society of America
- HDBUZZ: Switching it up: variety in the HD gene affects symptom onset
- 2015 Postcard from Palm Springs
- HDBuzz article – A faulty filter? Blood vessel changes in Huntington’s disease
- 2015 Huntington’s Disease Therapeutics Conference and taking part in trials
- Gene variant determines early or late onset of Huntington’s disease
- Life in HD: A Conversation with Lisa Genova Tickets Now on Sale
- Huntington’s Disease Society of America Announces Winners of 2015 Donald A. King Summer Research Fellowship
- Lighting the way: A new biomarker for Huntington’s disease
- Huntington’s Disease Society of America Launches HD TrialFinder First-Of-Its-Kind Clinical Trial Matching Service For Huntington’s Disease
- New York Times Bestselling Author Lisa Genova to release Inside the O’Briens
- Law Enforcement Toolkit II Webinar Now Available
- Huntington’s Disease Society of America Announces First-Ever HD Human Biology Project Awards
- Huntington’s Disease Society of America Endorses Enroll-HD
- Huntington’s Disease Society of America Announces Winners of the 2014 Donald A. King Summer Research Fellowship
- Pride-HD Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease
- HDSA appoints Director of Marketing & Communications
- World leader in movement disorders Professor Ira Shoulson joins Prana Board
- Pitt Study Demonstrates How Huntington’s Disease Protein Disrupts a Novel Cellular Pathway to Cause Death of Neurons
- Huntington’s Disease Society of America Launches First “HD News” App
- 2CARE HD Clinical Trial Stopped Early for Lack of Benefit
- HDBuzz: 2CARE Study of Coenzyme Q for Huntington’s Disease Ends
- Auspex Pharmaceuticals Completes Enrollment in Phase 3 Clinical Trial of SD-809 in Chorea Associated With Huntington’s Disease (FIRST-HD)
- Huntington’s Disease Society of America Awards Additional HD Human Biology Project
- Jang-Ho Cha, MD, PhD Appointed Chairman of the Board of Trustees at the Huntington’s Disease Society of America
- Global Outcomes Data and Possible New Therapies in the Huntington’s Pipeline
